Learn more about whether Corcept Therapeutics Incorporated or Merck & Co., Inc. is a better investment based on AAII's A+ ...

Merck (NYSE:MRK) has reached a licensing agreement worth nearly $2B with the Chinese drugmaker Jiangsu Hengrui ...

Learn more about whether Jazz Pharmaceuticals plc or Merck & Co., Inc. is a better investment based on AAII's A+ Investor ...

A federal judge ruled in favor of Merck in litigation accusing it of concealing the risks of Gardasil, a vaccine to prevent ...

Merck & Co., Inc. (MRK) said on Tuesday that it hasentered into an exclusive license agreement with China-based Jiangsu ...

Merck’s new formulation of the mega-blockbuster Keytruda, made in collaboration with Alteogen, could help to keep the drug’s ...

and Merck (NYSE:MRK) over an injectable version of the New Jersey-based pharma giant’s cancer blockbuster, Keytruda, according to the Wall Street Journal. Citing people familiar with the matter ...

While 163 workers are impacted by layoffs, Merck's large manufacturing facility in Upper Gwynedd continues to drive its ...

Merck has filed a petition with the U.S. Patent and Trademark Office to challenge seven of Halozyme’s patents. Halozyme said ...

Merck (NYSE: MRK) has opened a new 225,000-square-foot vaccine manufacturing facility in Durham. The pharmaceutical company, headquartered in New Jersey, is also in the process of developing ...

Per the deal terms, Merck (NYSE:MRK) will receive exclusive rights to develop, manufacture, and commercialize HRS-5346 globally except in Greater China. In exchange, the Rahway, New Jersey-based ...